An accomplished research professional, Dr. Anna Beryozkina has focused her career on taking part in the development and testing of new drugs and treatments to battle diseases such as cancer and rheumatoid arthritis. Alongside her research work, Dr. Anna Beryozkina regularly attends annual events of leading professional organizations, including the American College of Rheumatology (ACR).
According to ACR, arthritis is the most common medical condition that leads to disability among veterans in the United States, with one out of every three diagnosed with the condition. In spite of these alarming figures, the Department of Defense (DoD) has yet to earmark any funding to research arthritis and its effects on service members. That’s why ACR is joining with the Arthritis Foundation in calling upon Congress to take action and set aside $20 million of the DoD’s annual budget for arthritis research.
In his comments, retired U.S. Navy Commander and Arthritis Foundation supporter Steve Smith said that the data is overwhelming concerning the disproportionate impact arthritis has on U.S. veterans. He says that it’s long past due that Congress take action on this issue by setting aside this funding, which would be used to study new treatment options and prevention methods.
According to ACR, arthritis is the most common medical condition that leads to disability among veterans in the United States, with one out of every three diagnosed with the condition. In spite of these alarming figures, the Department of Defense (DoD) has yet to earmark any funding to research arthritis and its effects on service members. That’s why ACR is joining with the Arthritis Foundation in calling upon Congress to take action and set aside $20 million of the DoD’s annual budget for arthritis research.
In his comments, retired U.S. Navy Commander and Arthritis Foundation supporter Steve Smith said that the data is overwhelming concerning the disproportionate impact arthritis has on U.S. veterans. He says that it’s long past due that Congress take action on this issue by setting aside this funding, which would be used to study new treatment options and prevention methods.
